Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-19

FDA Approved: ADRENALIN (EPINEPHRINE IN SODIUM CHLORIDE) — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Adrenalin (epinephrine in sodium chloride) from Par Health USA, LLC, enabling continued marketing of this epinep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADRENALIN (Epinephrine)

Snippet

SUPPL AP for ADRENALIN (EPINEPHRINE IN SODIUM CHLORIDE) (EPINEPHRINE IN SODIUM CHLORIDE)